Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00771355 · ClinicalTrials.gov registry record
In Vivo Imaging of Pigmentary Disorders by Reflectance Confocal Microscopy
A clinical trial, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- 40
- Enrollment target
NCT00771355: Clinical Trial study, sponsored by Massachusetts General Hospital.
NCT00771355 is a clinical trial that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00771355 was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- 40 participants
- Enrollment target
Study Summary
This is a pilot study to evaluate the findings of the Reflectance Confocal Microscopy when performed in cutaneous pigmentary disorders, such as vitiligo, melasma, post-inflammatory hyper-pigmentation and hypo-pigmentation. Confocal Microscopy is a recent diagnostic technique that has been used for observation of skin conditions that affect the superficial layers of the skin.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2008-08 |
| Est. Completion | 2010-07 |
Why NCT00771355 stopped before completion
NCT00771355 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00771355 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00771355 about?
NCT00771355 is a clinical study titled "In Vivo Imaging of Pigmentary Disorders by Reflectance Confocal Microscopy". This is a pilot study to evaluate the findings of the Reflectance Confocal Microscopy when performed in cutaneous pigmentary disorders, such as vitiligo, melasma, post-inflammatory hyper-pigmentation and hypo-pigmentation. Confocal Microscopy is a recent diagnostic technique that has been used for o...
What is the current status of trial NCT00771355?
This trial is currently terminated. The enrollment target is 40 participants. The study started on 2008-08. Estimated completion is 2010-07.
Who is sponsoring clinical trial NCT00771355?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia